Profil
David L.
Berstein worked as a Patent Attorney at Genetics Institute LLC from 1985 to 1990.
He then worked as a Patent Counsel at BASF Bioresearch Corp.
from 1990 to 1993.
From 1993 to 2007, he worked at ARIAD Pharmaceuticals, Inc. as the Chief Patent Counsel & Senior Vice President.
He briefly worked as the Chief Patent Counsel & Senior Vice President at Cerulean Pharma, Inc. in 2008.
He later worked as the Chief Intellectual Property Officer & SVP at ARIAD Pharmaceuticals, Inc. from 2008 to 2011.
Berstein received his undergraduate degree from the University of Michigan and his graduate degree from Fordham University School of Law.
Anciens postes connus de David L. Berstein
| Sociétés | Poste | Fin |
|---|---|---|
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Conseiller Juridique Général | 01/05/2008 |
| ARIAD PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/06/2007 |
| BASF Bioresearch Corp. | Conseiller Juridique Général | 01/01/1993 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/1990 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de David L. Berstein
| University of Michigan | Undergraduate Degree |
| Fordham University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
| BASF Bioresearch Corp. | |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |